Inspire Medical Systems Pre-Tax Profit Margin 2017-2024 | INSP
Inspire Medical Systems pre-tax profit margin from 2017 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
Inspire Medical Systems Pre-Tax Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
2024-12-31 |
$0.80B |
$0.06B |
7.35% |
2024-09-30 |
$0.76B |
$0.04B |
4.89% |
2024-06-30 |
$0.71B |
$0.01B |
1.27% |
2024-03-31 |
$0.66B |
$-0.01B |
-2.12% |
2023-12-31 |
$0.63B |
$-0.02B |
-3.20% |
2023-09-30 |
$0.57B |
$-0.03B |
-5.61% |
2023-06-30 |
$0.53B |
$-0.04B |
-7.79% |
2023-03-31 |
$0.47B |
$-0.04B |
-9.23% |
2022-12-31 |
$0.41B |
$-0.05B |
-11.06% |
2022-09-30 |
$0.35B |
$-0.05B |
-14.41% |
2022-06-30 |
$0.30B |
$-0.04B |
-14.33% |
2022-03-31 |
$0.26B |
$-0.04B |
-16.03% |
2021-12-31 |
$0.23B |
$-0.04B |
-17.60% |
2021-09-30 |
$0.20B |
$-0.05B |
-22.89% |
2021-06-30 |
$0.18B |
$-0.05B |
-26.29% |
2021-03-31 |
$0.13B |
$-0.06B |
-41.79% |
2020-12-31 |
$0.12B |
$-0.06B |
-48.70% |
2020-09-30 |
$0.10B |
$-0.06B |
-60.42% |
2020-06-30 |
$0.08B |
$-0.06B |
-69.14% |
2020-03-31 |
$0.09B |
$-0.04B |
-47.13% |
2019-12-31 |
$0.08B |
$-0.03B |
-40.24% |
2019-09-30 |
$0.07B |
$-0.03B |
-40.28% |
2019-06-30 |
$0.06B |
$-0.03B |
-40.63% |
2019-03-31 |
$0.06B |
$-0.02B |
-42.11% |
2018-12-31 |
$0.05B |
$-0.02B |
-45.10% |
2018-09-30 |
$0.04B |
$-0.02B |
-50.00% |
2018-06-30 |
$0.04B |
$-0.02B |
-55.26% |
2018-03-31 |
$0.03B |
$-0.02B |
-60.61% |
2017-12-31 |
$0.03B |
$-0.02B |
-60.71% |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MEDICAL INFO SYS |
$4.756B |
$0.803B |
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
|